Hadox Research Labs · Science Intelligence
We watch the research landscape, compare papers with fair peers, read the full text and publish the receipts. No journal logo, citation count or model gets the last word alone.
Current truthThe ascendance engine is still building history. This edition is editorially selected, not algorithmically declared “rising.”
Comparison universe1,138 current candidates across 41 age, field and article-type cohorts.
Evidence gateEvery public dossier was read from an authorised full body. Abstract-only records remain ineligible.
As of25 Jul 2026
This public, sanitized index unites the observatory with Hadox's reviewed dossiers. Bibliographic metadata and measured signal states are visible; abstracts and source text are not.
Tracking is not endorsement. A row means Hadox is monitoring the paper or has completed a public dossier. Radar states appear only when measured against age-, field- and article-type peers; no metric is invented for editorial selections.
Read the selection method| Paper | Field | Radar state | Attention | Next review | Hadox |
|---|---|---|---|---|---|
| Wolves fear humans but learn quickly about us Proceedings of the National Academy of Sciences · 2026-03-16 · 10.1073/pnas.2602695123 | Genetics Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 32% · 17 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| A global screen for magnetically induced neuronal activity in the pigeon brain Science · 2026-03-12 · 10.1126/science.aea6425 | Biochemistry, Genetics and Molecular Biology Research article | Baseline Candidate · 1 signal point | 9 citations Cohort 93% · 109 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia The New England Journal of Medicine · 2026-03-12 · 10.1056/nejmoa2515458 | Medicine Research article | Baseline Candidate · 1 signal point | 43 citations Cohort 98% · 181 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Gene Therapy to Treat Profound Hearing Loss The New England Journal of Medicine · 2026-03-12 · 10.1056/nejme2514326 | Neuroscience Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 19% · 21 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Genetic Variation in Clinical Cohorts The New England Journal of Medicine · 2026-03-12 · 10.1056/nejmc2518638 | Genetics Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 32% · 17 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Goals for Opioid Use Disorder Medications — Protection, Remission, and Recovery The New England Journal of Medicine · 2026-03-12 · 10.1056/nejmx250023 | Public Health, Environmental and Occupational Health Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 31% · 13 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Helicobacter pylori Screen-and-Treat Programs for Gastric Cancer Prevention — IARC Working Group Report The New England Journal of Medicine · 2026-03-12 · 10.1056/nejmsb2515372 | Surgery Research article | Baseline Candidate · 1 signal point | 6 citations Cohort 72% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| In Other Journals Science · 2026-03-12 · 10.1126/science.aeh0793 | Arts and Humanities Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 50% · 7 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Megabase-scale human genome rearrangement with programmable bridge recombinases Science · 2026-03-12 · 10.1126/science.adz0276 | Molecular Biology Research article | Baseline Candidate · 1 signal point | 18 citations Cohort 99% · 67 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN The New England Journal of Medicine · 2026-03-12 · 10.1056/nejmc2600540 | Immunology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 8% · 13 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Polymyalgia Rheumatica The New England Journal of Medicine · 2026-03-12 · 10.1056/nejmcp2506817 | Pulmonary and Respiratory Medicine Research article | Baseline Candidate · 1 signal point | 7 citations Cohort 77% · 13 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Rapid evolution predicts demographic recovery after extreme drought Science · 2026-03-12 · 10.1126/science.adu0995 | Genetics Research article | Baseline Candidate · 1 signal point | 8 citations Cohort 91% · 17 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Reckoning with my ‘ghost years’: why a low publication rate doesn’t always reflect failure Nature · 2026-03-12 · 10.1038/d41586-025-04062-9 | Information Systems and Management Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 50% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia The New England Journal of Medicine · 2026-03-12 · 10.1056/nejmoa2511882 | Hematology Research article | Baseline Candidate · 1 signal point | 7 citations Cohort 50% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Seal and sea lion brains have evolved to support volitional control of vocal behavior and learning Science · 2026-03-12 · 10.1126/science.adx9367 | Ecology Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 33% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
These are the exact visual editions already shared by Hadox. Each one now has a canonical source, immutable assets and a visible workflow state; publication history never substitutes for scientific review.
01
The source is identified, but no authorised full body is available for Hadox review yet.
02
Published edition linked to a full-text Hadox evidence dossier.
03
This official-source story is awaiting the institutional evidence workflow.
Historical copy retained; correction logged in the workflow.
Today, 0 papers have enough history for a momentum score and 0 public dossiers were selected by an open ascendance gate. That is not a failure to hide; it is the calibration state.
current paper assessments from Crossref + Openalex
cohorts split by paper age, article type and discipline
baseline · 1 watch · 0 rising
01Observe attention against fair peers.
02Wait for enough history to measure velocity.
03Read the authorised full paper and map every claim.
04Make a separate editorial decision and publish the evidence.